Additional predictive factors include: maximal PSMA intensity (tumour-to-background uptake in the highest SUVmean lesion), and PSMA tumour heterogeneity on baseline 68Ga-PSMA-PET/CT. This evidence concerns the gene FOLH1 and neoplasm.